| Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia. | |
| | |
MedLine Citation:
|
PMID: 17206408 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Mutations that affect the splicing of pre-mRNA are a major cause of human disease. Familial dysautonomia (FD) is a recessive neurodegenerative disease caused by a T to C transition at base pair 6 of IKBKAP intron 20. This mutation results in variable tissue-specific skipping of exon 20. Previously, we reported that the plant cytokinin kinetin dramatically increases exon 20 inclusion in RNA isolated from cultured FD cells. The goal of the current study was to investigate the nature of the FD splicing defect and the mechanism by which kinetin improves exon inclusion, as such knowledge will facilitate the development of future therapeutics aimed at regulating mRNA splicing. In this study, we demonstrate that treatment of FD lymphoblast cell lines with kinetin increases IKBKAP mRNA and IKAP protein to normal levels. Using a series of minigene constructs, we show that deletion of a region at the end of IKBKAP exon 20 disrupts the ability of kinetin to improve exon inclusion, pinpointing a kinetin responsive sequence element. We next performed a screen of endogenously expressed genes with multiple isoforms resulting from exon skipping events and show that kinetin's ability to improve exon inclusion is not limited to IKBKAP. Lastly, we highlight the potential of kinetin for the treatment of other human splicing disorders by showing correction of a splicing defect in neurofibromatosis. |
| | |
Authors:
|
Matthew M Hims; El Chérif Ibrahim; Maire Leyne; James Mull; Lijuan Liu; Conxi Lazaro; Ranjit S Shetty; Sandra Gill; James F Gusella; Robin Reed; Susan A Slaugenhaupt |
Related Documents
:
|
17095158 - Sequence analysis of all identified open reading frames on the frontal temporal dementi... 15523648 - Transfer of a mitochondrial dna fragment to mcoln1 causes an inherited case of mucolipi... 8981948 - Identification of point mutations in 41 unrelated patients affected with menkes disease. 12737948 - A "null allele" mutation is responsible for erythropoietic protoporphyria in an israeli... 22734698 - Inferring genome-wide patterns of admixture in qataris using fifty-five ancestral popul... 15211638 - Family-based and case-control association studies of drd4 and dat1 polymorphisms in chi... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't Date: 2007-01-06 |
Journal Detail:
|
Title: Journal of molecular medicine (Berlin, Germany) Volume: 85 ISSN: 0946-2716 ISO Abbreviation: J. Mol. Med. Publication Date: 2007 Feb |
Date Detail:
|
Created Date: 2007-01-26 Completed Date: 2007-08-30 Revised Date: 2011-07-08 |
Medline Journal Info:
|
Nlm Unique ID: 9504370 Medline TA: J Mol Med (Berl) Country: Germany |
Other Details:
|
Languages: eng Pagination: 149-61 Citation Subset: IM |
Affiliation:
|
Center for Human Genetic Research, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Carrier Proteins
/
analysis,
drug effects,
genetics* Cell Line, Tumor Dysautonomia, Familial / drug therapy* Exons / drug effects Humans Kinetin / pharmacology, therapeutic use* Neurofibromatoses / drug therapy, genetics RNA Splicing / drug effects* RNA, Messenger / analysis, drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Carrier Proteins; 0/IKBKAP protein, human; 0/RNA, Messenger; 525-79-1/Kinetin |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: On the theory of reactive mixtures for modeling biological growth.
Next Document: Determination of polybrominated diphenyl ethers in environmental standard reference materials.